Fidelity Investments’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
Other funds holding PMCB
Fidelity Investments's PMCB Position: Q2 2025 in Review
Fidelity Investments held its PharmaCyte Biotech (PMCB) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5456.
Fidelity Investments first reported a position in PMCB in Q3 2021 and has held it in 1 quarter since. The position peaked at $2K in Q3 2021. 17 funds tracked by Wall St. Rank hold PMCB as of Q2 2025.
- Fidelity Investments held 0 shares of PharmaCyte Biotech worth $0 as of Q2 2025.
- Fidelity Investments left its PharmaCyte Biotech share count unchanged in Q2 2025.
- PharmaCyte Biotech made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2025, its #5456 holding.
- Fidelity Investments first reported a position in PharmaCyte Biotech in Q3 2021 and has held it in 1 quarter since.
- Fidelity Investments's PharmaCyte Biotech position peaked at $2K in Q3 2021.
- 17 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q2 2025.
Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.